Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak
The human
trial of Bharat Biotech's anti-Covid-19 vaccine Covaxin began at Rohtak's Post-Graduate
Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij
tweeted.
Human
trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak
today, Vij, who is also the Home and Science & Technology minister said.
Three
subjects were enrolled today. All have tolerated the vaccine very well. There
were no adverse effects, Vij further said in his tweet.
Bharat
Biotech got the country's drug regulator's approval to start clinical trials of
its anti-Corona vaccine Covaxin recently. Read More
Comments
Post a Comment